Zentalis Pharmaceuticals, Inc. (ZNTL)

USD 2.92

(-6.87%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 562.02 Million 539.31 Million 454.5 Million 365.55 Million 102.65 Million 40.99 Million
Total Current Assets 496.71 Million 451.93 Million 350.77 Million 345.1 Million 84.06 Million 26.67 Million
Cash And Short Term Investments 482.91 Million 437.37 Million 339.88 Million 338.5 Million 82.42 Million 25.15 Million
Cash and Cash Equivalents 28.03 Million 43.06 Million 59.71 Million 54.95 Million 82.42 Million 25.15 Million
Short Term Investments 454.88 Million 394.3 Million 280.17 Million 283.55 Million - -
Net Receivables - 7.04 Million 4.44 Million 417 Thousand 140 Thousand 917 Thousand
Inventory - -7.04 Million -4.43 Million - - -
Other Current Assets 13.79 Million 14.56 Million 10.87 Million 6.18 Million 1.5 Million 606 Thousand
Total Non-Current Assets 65.3 Million 87.37 Million 103.73 Million 20.45 Million 18.59 Million 14.32 Million
Net PPE 41.73 Million 50.07 Million 52.83 Million 3.61 Million 2.83 Million 260 Thousand
Good Will And Intangible Assets 3.73 Million 3.73 Million 3.73 Million 12.53 Million 12.53 Million 12.53 Million
Good Will 3.73 Million 3.73 Million 3.73 Million 3.73 Million 3.73 Million 3.73 Million
Intangible Assets - - - 8.8 Million 8.8 Million 8.8 Million
Long-Term Investments 2.68 Million 21.21 Million 37.49 Million 1.32 Million 243 Thousand -46.26 Thousand
Tax Assets 10.33 Million 14.14 Million 7.04 Million 637 Thousand 751 Thousand 46.26 Thousand
Other Non Current Assets 6.81 Million -1.79 Million 2.62 Million 2.33 Million 2.22 Million 1.52 Million
Other Assets - - - - 0.00 -
Total Liabilities 124.63 Million 105.28 Million 90.02 Million 32.17 Million 19.06 Million 8.69 Million
Total Current Liabilities 69.36 Million 56.64 Million 43.94 Million 28.6 Million 14.89 Million 6.2 Million
Account Payables 14.92 Million 11.24 Million 11.59 Million 8.66 Million 4.28 Million 3.43 Million
Tax Payables 281 Thousand - 971 Thousand 410 Thousand - -
Short Term Debt 2.62 Million 2.16 Million 1.45 Million 902 Thousand 781 Thousand -223.42 Thousand
Deferred Revenue 281 Thousand -2.16 Million - - - 223.42 Thousand
Other Current Liabilities 51.53 Million 45.4 Million 30.9 Million 19.03 Million 9.82 Million 2.77 Million
Total Non Current Liabilities 55.26 Million 48.63 Million 46.08 Million 3.57 Million 4.16 Million 2.48 Million
Long-Term Debt 43.15 Million 45.16 Million 44.45 Million 1.09 Million - -
Deferred Revenue Non Current -1.00 - -1622.00 -1.09 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.78 Million 2.62 Million 1622.00 1.09 Million 1.7 Million 21 Thousand
Other Liabilities 1.00 - - - - -
Total Equity 437.39 Million 434.24 Million 365.01 Million 358.17 Million 83.59 Million 32.3 Million
Stock Holders Equity 437.28 Million 434.02 Million 364.48 Million 333.37 Million 76.77 Million 24.77 Million
Common Stock 70 Thousand 59 Thousand 45 Thousand 41 Thousand 25 Thousand 2.27 Million
Retained Earnings -888.55 Million -596.36 Million -359.55 Million -200.83 Million -82.99 Million -37.33 Million
Accumulated other comprehensive income 2.19 Million -1.35 Million -125 Thousand 36 Thousand -141.7 Million -56 Thousand
Common Stock Equity 437.28 Million 434.02 Million 364.48 Million 333.37 Million 76.77 Million 24.77 Million
Capital Lease Obligation 43.15 Million 45.16 Million 45.91 Million 1.99 Million 781 Thousand -
Total Investments 457.56 Million 415.51 Million 317.66 Million 283.55 Million 243 Thousand -46.26 Thousand
Total Debt 45.77 Million 45.16 Million 45.91 Million 1.99 Million 781 Thousand -
Net Debt 17.73 Million 2.09 Million -13.8 Million -52.95 Million -81.64 Million -25.15 Million

Balance Sheet Charts